Potential New Drugs in Lymphoma

Potential New Drugs in Lymphoma

Lymphomas are malignant tumours arising from cells in the lymphatic system. They are classified as B-cell lymphomas, T-cell lymphomas and Hodgkin lymphoma (HL). Of the B-cell lymphomas, one of the most common is diffuse large B-cell lymphoma (DLBCL). Many patients with lymphomas can be successfully...

Full description

Bibliographic Details
Main Author:	Delforoush, Maryam
Format:	Doctoral Thesis
Language:	English
Published:	Uppsala universitet, Institutionen för immunologi, genetik och patologi 2016
Subjects:	lymphoma diffuse large B-cell lymphoma DLBCL picropodophyllin PPP J1 melflufen prodrug cancer therapeutics alkylating agents b-AP15 proteasome inhibitors DUB inhibition UCHL5 USP14
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-280546 http://nbn-resolving.de/urn:isbn:978-91-554-9524-4

Similar Items

The Bench of Primary Breast Lymphoma Treatment: A Review of the Literature and a Case Report
by: Saeed Karimkhani Zandi, et al.
Published: (2017-12-01)

When Imaging Predicts Aggressiveness of Large B Cell Lymphoma Biology
by: Minhas, Ahmed, et al.
Published: (2018)

Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma
by: Liling Jiang, et al.
Published: (2019-11-01)

Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma
by: Erika Larrea, et al.
Published: (2020-11-01)

Gastro-Splenic Fistula Related to Large B Cell Lymphoma
by: Diana Triantafyllopoulou, et al.
Published: (2020-06-01)

Diffuse large B cell lymphoma primarily presenting as acute liver failure in a surviving patient
by: Jumpei Shibata, et al.
Published: (2019-03-01)

NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment
by: Dang-Nghiem Vo, et al.
Published: (2018-04-01)

BRIDGING TO TRANSPLANT IN DIFFUSE LARGE B CELL LYMPHOMA
by: Christian Gisselbrecht, et al.
Published: (2016-07-01)

Biweekly CHOP therapy improves therapeutic effect in the non-GCB subtype of diffuse large B-cell lymphoma
by: Zhang Qingyuan, et al.
Published: (2007-12-01)

Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
by: Jean-Ehrland Ricci, et al.
Published: (2018-12-01)

Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review
by: Philippe Decruyenaere, et al.
Published: (2021-02-01)

Comparative Study on Rituximab Combined with Chemotherapy and Single Chemotherapy for Diffuse Large B Cell Lymphoma
by: Ji-feng FENG
Published: (2015-06-01)

Gemcitabine, dexamethasone, and cisplatin salvage in relapsed lymphomas: A single institutional experience
by: Avaronnan Manuprasad, et al.
Published: (2020-01-01)

PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro
by: Cui W, et al.
Published: (2017-04-01)

Low Expression of 14-3-3beta Is Associated With Adverse Survival of Diffuse Large B-Cell Lymphoma Patients
by: Chaoping Li, et al.
Published: (2019-10-01)

Report of a case of primary breast lymphoma highlighting the importance of fine needle aspiration cytology as an initial diagnostic tool
by: Millu F Jain, et al.
Published: (2015-01-01)

Primary gastrointestinal diffuse large B-cell lymphoma: A prospective study from South India
by: Babu Suresh, et al.
Published: (2019-01-01)

Anaplastic Lymphoma Kinase positive large B cell lymphoma of ileocaecal mesentery: A case report
by: Aravinth Subramaniam, et al.
Published: (2020-01-01)

Bispecific Antibodies: A Review of Development, Clinical Efficacy and Toxicity in B-Cell Lymphomas
by: Ross Salvaris, et al.
Published: (2021-04-01)

Successful Treatment of Gastrosplenic Fistula Arising from Diffuse Large B-Cell Lymphoma with Chemotherapy: Two Case Reports
by: Makoto Saito, et al.
Published: (2019-05-01)

An unusual case report of primary cerebellar T-cell lymphoma and review of the literature
by: Ran Zeng, et al.
Published: (2021-06-01)

Composite lymphoma with coexistence of diffuse large B-cell lymphoma and anaplastic large cell lymphoma: Diagnostic pitfalls
by: Meyyappa Devan Rajagopal, et al.
Published: (2017-01-01)

A rare case of de novo CD5+ diffuse large B-cell lymphoma in leukemic phase and positive for CD13
by: Giovanni Carulli, et al.
Published: (2018-01-01)

MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index
by: Hanne Due, et al.
Published: (2020-03-01)

Primary Diffuse Large B-Cell Lymphoma of the Sigmoid Colon
by: Minhas, Ahmed, et al.
Published: (2019)

Absence of Non-Canonical, Inhibitory MYD88 Splice Variants in B Cell Lymphomas Correlates With Sustained NF-κB Signaling
by: Yamel Cardona Gloria, et al.
Published: (2021-06-01)

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
by: Peifeng Li, et al.
Published: (2021-03-01)

18F-FDG PET/CT imaging findings in anaplastic large cell lymphoma, a rare subtype of lymphoma
by: Yanping Jiang, et al.
Published: (2020-01-01)

Primary extranodal lymphomas - spectrum of distribution and morphology with immunophenotyping: A 3-year institutional study
by: Chinnam Aparna, et al.
Published: (2015-01-01)

Composite lymphoma of T-cell rich, histiocyte-rich diffuse large B-cell lymphoma and nodular lymphocyte predominant Hodgkin lymphoma: a case report
by: Asil Esper, et al.
Published: (2021-04-01)

Étude des mécanismes de survie des cellules lymphoïdes B malignes : 1- Rôle de l’enzyme de déubiquitination USP14 : 2- Effet du fingolimod dans la mort indépendante des caspases
by: Dubois, Nicholas
Published: (2014)

Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice
by: Carlo Visco, et al.
Published: (2020-10-01)

Primary gastrointestinal lymphoma
by: Amir Aledavood, et al.
Published: (2012-01-01)

The Deubiquitinating Enzyme USP14 Regulates Leukemic Chemotherapy Drugs-Induced Cell Apoptosis by Suppressing Ubiquitination of Aurora Kinase B
by: Chunge Song, et al.
Published: (2017-06-01)

Clinicopathological study and outcomes of primary extranodal lymphoma
by: Nichapa Nanthakwang, et al.
Published: (2019-11-01)

Exceptional Responder to Immunotherapy: A Rare Case of Post- HSCT DLBCL Relapse Responding to Nivolumab
by: Irappa Madabhavi, et al.
Published: (2019-04-01)

Our Primary Colorectal Lymphoma Experiences
by: Ebubekir Gündeş, et al.
Published: (2014-06-01)

Primary Pancreatic Lymphoma: Recommendations for Diagnosis and Management
by: Facchinelli D, et al.
Published: (2021-05-01)

Primary Liver Lymphoma Presenting as Liver Nodules
by: João Manuel Silva, et al.
Published: (2020-06-01)

Prognostic impact of immunohistochemical and molecular genetic markers in Diffuse Large B-cell lymphoma
by: E. V. Kharchenko, et al.
Published: (2019-12-01)